breast cancer cells

[Journal of Cellular and Molecular Medicine] Scientists illustrated and summarized the correlations between endocrine therapy resistance in breast cancer and prolactin (PRL), as well as the pathophysiological mechanisms and clinical practices.

[Scientific Reports] Scientists investigated the cell viability and electrical response of graphene oxide (GO), in terms of resistivity and impedance towards the breast cancer cells and normal breast cells, by varying the pH and concentration of GO.

[Molecular Therapy-Nucleic Acids] The authors reported DGUOK-AS1 overexpression promoted breast cancer cell migration, angiogenesis, and macrophage migration, mediated by the increased secretion of IL11, which was extremely important for cancer progression.

[Cell Death & Disease] The authors showed that TRIM31 was downregulated in breast cancer tissues and negatively correlated with breast cancer progression. Both gain- and loss-of-function assays indicated that TRIM31 inhibited the proliferation, colony formation, migration, and invasion of breast cancer cells.

[Breast Cancer Research] Researchers showed that fluid forces on the order of 1 Pa promoted epithelial-to-mesenchymal transition and adhesion of breast cancer cells to an endothelial monolayer and identified biomarkers were distinctly expressed in patient populations.

[Breast Cancer Research] Scientists investigated the effect of oestrogen deprivation on the expression of chemokines and immune infiltration in vitro and in an ER+ immunocompetent mouse model.